LAURA MUNIZ: Open Payments
NPI 1851870505 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 15 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $164 · 2025 $407
Food & beverage: $407
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $149 |
| Novo Nordisk Inc | 4 | $74 |
| Medtronic, Inc. | 1 | $41 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Lilly USA, LLC | 1 | $27 |
| Ardelyx, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
Products named: AIRSUPRA, Wegovy, VECTRIS SURESCAN, SHINGRIX, GEMTESA, MOUNJARO, BREZTRI, IBSRELA.
Industry payments across TX — which companies pay providers there.
